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Sunday, March 1, 2009 67astructures. This method is unique in providing ‘‘local’’ structural information in
solution for gaining insight into dynamic processes involving, large RNA-pro-
tein and protein-protein assemblies on biologically relevant timescales. The
method also can uniquely probe the ‘‘local’’ structure of large complexes
poised at equilibrium for functional states of interest, and has been extended
to in vivo studies.
Beamline X28C is located at the National Synchrotron Light Source of Broo-
khaven National Laboratory. An expanding set of user groups utilize this na-
tional resource funded by the National Institute of Biomedical Imaging and Bio-
engineering of the National Institutes of Health. The facility is operated by the
Center for Synchrotron Biosciences and the Center for Proteomics and Bioinfor-
matics of Case Western Reserve University. The facility supports both onsite and
offsite user access. Beam time is allocated online through peer reviewed user
proposal system. Examples of recent research projects are provided.
343-Pos Board B222
Expression and Purification of the Myxoma Virus Leukemia Associated
Protein Zinc Finger Domain
Bryan G. Hahn1, Dominic Esposito2, Dana C. Lawrence1.
1Hood College, Frederick, MD, USA, 2SAIC-Frederick, Frederick, MD,
USA.
Myxoma Virus Leukemia Associated Protein (MV-LAP) is a protein encoded
by Myxoma virus, a poxvirus responsible for the lethal disease, myxomatosis in
the European Rabbit. MV-LAP has developed a ‘‘stealth’’ mechanism to evade
the host immune system by reducing the expression of major histocompatibility
complex (MHC)-1 molecules, responsible for identifying self vs. non-self an-
tigens. In order to help understand this stealth mechanism, the N-terminal do-
main (NTD; 94 residues) of MV-LAP will be characterized structurally using
NMR. The current project builds upon the purification of the MV-LAP-Maltose
Binding Protein fusion protein system and the purification of MV-LAP NTD.
Purification of the fusion protein occurred via the use of a Co2þ Immobilized
Metal ion Affinity Chromatography (IMAC) column. Several buffer systems
allow for the purification of a soluble fusion protein. In addition, several buffer
systems were evaluated for the use in the purification of MV-LAP NTD. The
purification of a soluble form of MV-LAP NTD and the preparation of a sample
for NMR analysis is currently underway.
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Ever since the discovery of viruses so many years ago there have been re-
searchers of many different fields racing to find the perfect inhibitor. Any and
all discoveries of viral resistance have been taken into a spotlight to discover
the mechanisms. Zinc Finger Antiviral Protein (ZAP) is found in the kidney
and liver cells of Rattus norvegicus; this protein makes these cells more resistant
to viral infection. Gao et al concluded that ZAP facilitates inhibition of the anti-
viral gene expression, one of the major propagation steps (rather than inhibition
of infection ZAP affects viral expression) by binding viral mRNA. Since then
ZAP has been shown to increase resistance against Moloney Murine Leukemia
virus, Sindbis virus, Ebola virus, and Marburg virus. Activity of ZAP containing
four CCCH zinc fingers seems to be dependent on the integrity of the second and
fourth CCCH zinc fingers. With HIV in mind, which is also a retrovirus, we have
concluded that ZAP will have profound and influential implications.
Our goal is to determine the structure of the zinc-binding domain of ZAP using
Nuclear Magnetic Resonance. Zap was expressed as a fusion protein in E. coli
with several different cleavage conditions and purified using Immobilized
Metal Ion Affinity Chromatography (IMAC) were screened and found unsuc-
cessful in that the cleaved ZAP was insoluble. However, we are currently
working on the smaller ZAP proteins that only contain two zinc fingers; their
constructs show promising results in terms of solubility after cleavage.
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The human cardiac TnT deletion 96 (HcTnT3-DE96) has been linked to Re-
strictive Cardiomyopathy and causes a dramatic increase in Ca2þ sensitivity
of force development (J Biol Chem 283(4):2156-66). Here, we present further
biochemical and functional studies to assess whether there are additional fac-
tors contributing to the severity of the phenotype. To determine whether the
RCM mutation interferes with the cTnI-PKA phosphorylation signal, thatdecreases Ca2þ sensitivity of the myofilament upon b-adrenergic stimulation,
we utilized a cTnI phosphorylation mimetic. The Ca2þ sensitivity of force de-
velopment was evaluated in porcine cardiac skinned fibers using cTnT dis-
placement (HcTnT3-WT or HcTnT3-DE96) followed by reconstitution with
the binary complex containing pseudo-phosphorylated cTnI (where serines
23, 24 were replaced with aspartic acid - cTnISS/DD.cTnC) or the non-phosphor-
ylatable control cTnI (where serines 23, 24 were mutated to alanine - cTnISS/
AA.cTnC). Fibers displaced with HcTnT3-WT and reconstituted with cTnISS/
DD.cTnC showed a decrease in the Ca
2þ sensitivity compared to the control
reconstituted with cTnISS/AA.cTnC. In contrast, fibers displaced with HcTnT3-
DE96 and reconstituted with cTnISS/DD.cTnC or cTnISS/AA.cTnC showed sim-
ilar Ca2þ sensitivities. These results indicate that the mutation may ablate the
effects of cTnI PKA phosphorylation. Additionally, Circular dichroism (CD)
studies using 0.5M NaF showed a decreased a-helical content of HCTnT3-
DE96 compared to HCTnT3-WT. CD thermal denaturation measuring the
a-helical content at 222 nm revealed that the mutant unfolded earlier and at
a drastically reduced Tm compared to WT. Furthermore, Troponin complexes
containing cTnC-IAANS labeled at both Cys 35 and 84 with HcTnT3-D96
did not show alterations in the apparent Ca2þ affinity of the cTnC low affinity
site II compared to troponin complex containing HcTnT3-WT. Work supported
by NIH HL-042325 (J.D.P.) and Postdoctoral Fellowship AHA 0825368E
(J.R.P.).
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MitoNEET, a recently discovered 2Fe-2S containing outer mitochondrial pro-
tein (1), was identified as a binding target for pioglitazone, an insulin-sensitiz-
ing drug of the thiazolidinedione class used in the treatment of type 2 diabetes
(2). MitoNEET possesses a unique dimeric structure, with a new fold (3). The
pH sensitive lability of the 2Fe-2S cluster was attributed to protonation of the
conserved solvent accessible His87 (Figure). Its replacement with Cys in-
creased the stability of the cluster ~10-fold (1). The crystal structure of the
H87C mutant (1.8A˚, Rfactor ¼ 18%) shows that the Sg of Cys87 remains at
a similar position to the Nd of His87 in the native (Figure). The only other
change was a reorientation of Lys55.
Thus, the increased stability of the
HC87 mutant is attributed to the specific
change in the ligation of the 2Fe-2S
cluster, not a more global conforma-
tional change.
(1) Wiley et al. (2007) J Biol Chem. 282,
23745-23749.
(2) Colca et al. (2004) Am J Physiol En-
docrinol Metab 286, E252-E260.
(3) Paddock et al. (2007) Proc Natl.
Acad. Sci USA 104, 14342-14347.
*Supported by NIH (GM41637,
GM54038 and DK5441).
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C-type lysozyme catalyzes the hydrolysis of peptidoglycan of bacterial cell
wall. Most of C-type lysozymes express to protect body against bacterial infec-
tion. However, ruminants and some leaf-eating animals have evolved their ly-
sozyme as digestive enzyme. They recruit bacteria which ferment cellulose in
the foregut, and digest the bacteria by lysozyme in the true stomach to obtain
nutrient. Digestive lysozyme has acquired some properties, such as low optimal
pH, and resistance to protease and acid hydrolysis. The structural basis for these
properties still remains unclear. In this investigation, we have obtained the crys-
tallographic structure of bovine stomach lysozyme (BSL). This is the first re-
port on the structure of vertebrate digestive lysozyme. We have carried out
the denaturant-unfolding experiment and revealed that BSL has high structural
stability at acidic pH compared to non-digestive (hen egg-white) lysozyme. The
structural stability in acidic solution would be related to the pepsin resistance
